The Mexico Schizophrenia Drugs Market is projected to grow from USD 148.99 million in 2024 to USD 196.45 million by 2033, registering a CAGR of 3.12% during 2025–2033, according to Renub Research. The market growth is being driven by the rising prevalence of schizophrenia and related mental health disorders, increased mental health awareness, government initiatives, […]